FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311791444> ?p ?o ?g. }

• W4311791444 endingPage "439" @default.
• W4311791444 startingPage "439" @default.
• W4311791444 abstract "Human cytomegalovirus (HCMV) is ubiquitous worldwide and elicits global health problems. The diseases associated with HCMV are a serious threat to humans, especially for the sick, infant, elderly and immunocompromised/immunodeficient individuals. Although traditional antiviral drugs (e.g., ganciclovir, valganciclovir, cidofovir, foscarnet) can be used to treat or prevent acute HCMV infections, their efficacy is limited because of toxicity, resistance issues, side effects and other problems. Fortunately, novel drugs (e.g., letermovir and maribavir) with less toxicity and drug/cross-resistance have been approved and put on the market in recent years. The nucleic acid-based gene-targeting approaches including the external guide sequences (EGSs)-RNase, the clustered regularly interspaced short palindromic repeats (CRISPRs)/CRISPRs-associated protein 9 (Cas9) system and transcription activator-like effector nucleases (TALENs) have been investigated to remove both lytic and latent CMV in vitro and/or in vivo. Cell therapy including the adoptive T cell therapy (ACT) and immunotherapy have been tried against drug-resistant and recurrent HCMV in patients receiving hematopoietic stem cell transplantation (HSCT) or solid organ transplant (SOT), and they have also been used to treat glioblastoma (GBM) associated with HCMV infections. These newly developed antiviral strategies are expected to yield fruitful results and make a significant contribution to the treatment of HCMV infections. Despite this progress, the nucleic acid-based gene-targeting approaches are still under study for basic research, and cell therapy is adopted in a small study population size or only successful in case reports. Additionally, no current drugs have been approved to be indicated for latent infections. Therefore, the next strategy is to develop antiviral strategies to elevate efficacy against acute and/or latent infections and overcome challenges such as toxicity, resistance issues, and side effects. In this review, we would explore the challenges, recent advances and perspectives in the treatment of HCMV infections. Furthermore, the suitable therapeutic strategies as well as the possibility for compassionate use would be evaluated." @default.
• W4311791444 created "2022-12-28" @default.
• W4311791444 creator A5008534797 @default.
• W4311791444 creator A5023139246 @default.
• W4311791444 creator A5042882484 @default.
• W4311791444 date "2022-12-14" @default.
• W4311791444 modified "2023-10-14" @default.
• W4311791444 title "Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections" @default.
• W4311791444 cites W156896671 @default.
• W4311791444 cites W1570861013 @default.
• W4311791444 cites W1810340630 @default.
• W4311791444 cites W1941291045 @default.
• W4311791444 cites W1957027480 @default.
• W4311791444 cites W1999722506 @default.
• W4311791444 cites W2024742459 @default.
• W4311791444 cites W2031208709 @default.
• W4311791444 cites W2042389250 @default.
• W4311791444 cites W2049693838 @default.
• W4311791444 cites W2072734814 @default.
• W4311791444 cites W2075424306 @default.
• W4311791444 cites W2085476296 @default.
• W4311791444 cites W2087691232 @default.
• W4311791444 cites W2092301367 @default.
• W4311791444 cites W2115048527 @default.
• W4311791444 cites W2123344591 @default.
• W4311791444 cites W2123509633 @default.
• W4311791444 cites W2128162207 @default.
• W4311791444 cites W2129481598 @default.
• W4311791444 cites W2131480973 @default.
• W4311791444 cites W2133963802 @default.
• W4311791444 cites W2142404794 @default.
• W4311791444 cites W2146404990 @default.
• W4311791444 cites W2154023678 @default.
• W4311791444 cites W2159702641 @default.
• W4311791444 cites W2171487914 @default.
• W4311791444 cites W2223532395 @default.
• W4311791444 cites W2226865313 @default.
• W4311791444 cites W2262092682 @default.
• W4311791444 cites W2319786453 @default.
• W4311791444 cites W2340930756 @default.
• W4311791444 cites W2464177244 @default.
• W4311791444 cites W2521436102 @default.
• W4311791444 cites W2533435998 @default.
• W4311791444 cites W2587030638 @default.
• W4311791444 cites W2589992361 @default.
• W4311791444 cites W2606625852 @default.
• W4311791444 cites W2615860428 @default.
• W4311791444 cites W2659662159 @default.
• W4311791444 cites W2699697708 @default.
• W4311791444 cites W2765343225 @default.
• W4311791444 cites W2766238164 @default.
• W4311791444 cites W2774621607 @default.
• W4311791444 cites W2789794149 @default.
• W4311791444 cites W2791913390 @default.
• W4311791444 cites W2796509983 @default.
• W4311791444 cites W2797220463 @default.
• W4311791444 cites W2804566227 @default.
• W4311791444 cites W2805496449 @default.
• W4311791444 cites W2811351313 @default.
• W4311791444 cites W2883792147 @default.
• W4311791444 cites W2884395227 @default.
• W4311791444 cites W2887155687 @default.
• W4311791444 cites W2889030797 @default.
• W4311791444 cites W2895176731 @default.
• W4311791444 cites W2897822636 @default.
• W4311791444 cites W2903411772 @default.
• W4311791444 cites W2904685881 @default.
• W4311791444 cites W2911460858 @default.
• W4311791444 cites W2912664742 @default.
• W4311791444 cites W2921309766 @default.
• W4311791444 cites W2927314704 @default.
• W4311791444 cites W2927356069 @default.
• W4311791444 cites W2942355054 @default.
• W4311791444 cites W2943558046 @default.
• W4311791444 cites W2948118452 @default.
• W4311791444 cites W2949531420 @default.
• W4311791444 cites W2950495019 @default.
• W4311791444 cites W2955606903 @default.
• W4311791444 cites W2964081991 @default.
• W4311791444 cites W2964702665 @default.
• W4311791444 cites W2969930222 @default.
• W4311791444 cites W2970771745 @default.
• W4311791444 cites W2971750405 @default.
• W4311791444 cites W2974287296 @default.
• W4311791444 cites W2977630397 @default.
• W4311791444 cites W2986696307 @default.
• W4311791444 cites W2986699023 @default.
• W4311791444 cites W2989552478 @default.
• W4311791444 cites W2995975045 @default.
• W4311791444 cites W3000230500 @default.
• W4311791444 cites W3002795241 @default.
• W4311791444 cites W3005149509 @default.
• W4311791444 cites W3007169846 @default.
• W4311791444 cites W3012901598 @default.
• W4311791444 cites W3021730549 @default.
• W4311791444 cites W3033977445 @default.
• W4311791444 cites W3093517553 @default.
• W4311791444 cites W3098358472 @default.

• next